1. Home
  2. CENX vs HAE Comparison

CENX vs HAE Comparison

Compare CENX & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Aluminum Company

CENX

Century Aluminum Company

HOLD

Current Price

$46.72

Market Cap

4.6B

Sector

Industrials

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$90.80

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENX
HAE
Founded
1995
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Aluminum
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
3.8B
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
CENX
HAE
Price
$46.72
$90.80
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$65.67
$84.13
AVG Volume (30 Days)
2.1M
738.0K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
5.62
0.72
Revenue
$1,893,200,000.00
$910,373,000.00
Revenue This Year
$20.77
N/A
Revenue Next Year
$14.58
$5.23
P/E Ratio
$8.25
$125.53
Revenue Growth
N/A
N/A
52 Week Low
$20.92
$47.32
52 Week High
$70.43
$92.25

Technical Indicators

Market Signals
Indicator
CENX
HAE
Relative Strength Index (RSI) 49.19 71.51
Support Level $42.50 $79.52
Resistance Level $48.28 N/A
Average True Range (ATR) 2.70 3.10
MACD 0.46 0.44
Stochastic Oscillator 37.79 91.84

Price Performance

Historical Comparison
CENX
HAE

About CENX Century Aluminum Company

Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. The company also owns a carbon anode production facility in the Netherlands.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: